PART I.    FINANCIAL INFORMATION
		Item 1.		Financial Statements
				Condensed Consolidated Balance Sheets June 30, 2002 and March 31, 2002		3
				Condensed Consolidated Statements of Operations Three Months Ended June 30, 2002 and 2001		4
				Condensed Consolidated Statements of Cash Flows Three Months Ended June 30, 2002 and 2001		5
				Notes to Condensed Consolidated Financial Statements		6
		Item 2.		Management’s Discussion and Analysis of Financial Condition and Results of Operations		15
		Item 3.		Quantitative and Qualitative Disclosures About Market Risk		32
PART II.    OTHER INFORMATION
		Item 1.		Legal Proceedings		35
		Item 2.		Changes in Securities and Use of Proceeds		36
		Item 3.		Defaults Upon Senior Securities		36
		Item 4.		Submission of Matters to a Vote of Security Holders		36
		Item 5.		Other Information		36
		Item 6.		Exhibits and Reports on Form 8-K		37
		Signatures				38

		June 30, 2002				March 31, 2002
ASSETS
Current assets:
Cash and cash equivalents		$	96,250			$	66,874
Short-term investments			72,952				95,097
Total cash, cash equivalents and short-term investments			169,202				161,971
Accounts receivable, net			38,304				24,181
Prepaid expenses and other current assets			27,268				30,545
Total current assets			234,774				216,697
Related party loans			8,409				8,305
Fixed assets, net			46,727				49,189
Intangible assets, net			223,215				226,579
Restricted cash			10,922				11,409
Other non-current assets			4,751				5,659
Total assets		$	528,798			$	517,838
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable		$	7,039			$	6,719
Accrued liabilities			59,611				56,082
Accrued restructuring, current			10,789				12,224
Unearned revenues			29,716				24,791
Total current liabilities			107,155				99,816
Accrued restructuring, non-current			28,772				30,809
Other non-current liabilities			6,499				6,492
Total liabilities			142,426				137,117
Stockholders’ equity:
Common stock and additional paid-in capital, par value $0.001 per common share; 200,000 shares authorized; 61,601 and 60,987 shares issued at June 30, 2002 and March 31, 2002, respectively			743,612				734,816
Treasury stock at cost; 1,818 common shares at June 30, 2002 and March 31, 2002			(33,649	)			(33,649	)
Deferred stock compensation			(182	)			(281	)
Accumulated other comprehensive loss			(1,418	)			(158	)
Accumulated deficit			(321,991	)			(320,007	)
Total stockholders’ equity			386,372				380,721
Total liabilities and stockholders’ equity		$	528,798			$	517,838

		Three Months Ended June 30,
		2002				2001
Net revenues		$	83,689			$	88,743
Cost of revenues			10,506				11,137
Gross profit			73,183				77,606
Operating expenses:
Sales and marketing			37,378				48,621
Research and development			26,372				29,946
General and administrative			10,613				12,736
Restructuring expenses			—				39,539
Amortization of intangible assets			3,364				29,065
Total operating expenses			77,727				159,907
Operating loss			(4,544	)			(82,301	)
Other income (expense):
Interest income and other, net			1,148				2,826
Loss on investments			(803	)			(6,683	)
Loss on equity affiliate			—				(26,861	)
Litigation settlements			2,822				—
Total other income (expense)			3,167				(30,718	)
Loss before income taxes			(1,377	)			(113,019	)
Provision (benefit) for income taxes			607				(1,245	)
Net loss		$	(1,984	)		$	(111,774	)
Net loss per common share:
Basic and diluted		$	(0.03	)		$	(1.94	)
Weighted average common shares outstanding used in calculating net loss per common share:
Basic and diluted			59,550				57,522

		Three Months Ended June 30,
		2002				2001
Cash flows from operating activities:
Net loss		$	(1,984	)		$	(111,774	)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization			7,974				41,801
Deferred income taxes			—				(2,198	)
Impairment of long-lived assets			—				13,062
Loss on investments			803				6,683
Loss on equity affiliate			—				26,861
Change in operating assets and liabilities:
Accounts receivable, net			(14,123	)			7,358
Prepaid expenses and other current assets			3,742				1,853
Accrued liabilities and payables			2,558				(16,965	)
Accrued restructuring			(3,472	)			21,880
Unearned revenues			4,925				857
Net cash provided by (used in) operating activities			423				(10,582	)
Cash flows from investing activities:
Capital expenditures			(2,342	)			(10,357	)
Purchases of available-for-sale short-term investments			(13,566	)			(26,057	)
Maturities and sales of available-for-sale short-term investments			35,536				35,917
Purchases of investments			—				(2,995	)
Release (deposits) of restricted cash			487				(2,207	)
Other, net			43				(785	)
Net cash provided by (used in) investing activities			20,158				(6,484	)
Cash flows from financing activities:
Proceeds from issuance of common stock			8,795				3,113
Net cash provided by financing activities			8,795				3,113
Net increase (decrease) in cash and cash equivalents			29,376				(13,953	)
Cash and cash equivalents, beginning of period			66,874				116,507
Cash and cash equivalents, end of period		$	96,250			$	102,554